Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma
Journal of the American Veterinary Medical Association · 2023
DOI: 10.2460/javma.23.02.0102 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Veterinary Medical Association, 2023. Verfasst von Maureen A Griffin und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA. Hauptthemen laut MEDLINE: Adenocarcinoma, Anal Gland Neoplasms, Anal Sacs, Dog Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE To evaluate short- and long-term outcomes for dogs undergoing anal sacculectomy for massive (> 5 cm) apocrine gland anal sac adenocarcinoma (AGASACA). ANIMALS 28 client-owned dogs with massive AGASACA. PROCEDURES A retrospective multi-institutional study was performed. Pre-, intra-, and post-operative data was collected, and variables were statistically analyzed for associations with progression-free interval (PFI) and overall survival (OS). RESULTS At the time of anal sacculectomy, 19 (68%) dogs underwent concurrent iliosacral lymph node extirpation, including 17 of 18 (94%) dogs with suspected nodal metastasis preoperatively. Five (18%) dogs experienced grade 2 intraoperative complications. Ten (36%) dogs experienced postoperative complications, including 1 grade 3 and 1 grade 4 complication. No dogs had permanent fecal incontinence, tenesmus, or anal stenosis. Nineteen dogs received adjuvant chemotherapy, radiation, or both. Local recurrence occurred in 37% of dogs. Dogs with lymph node metastasis at surgery were more likely than dogs without metastasis to develop new/progressive lymph node metastasis (10/17 [59%] vs 0/10 [0%]; P = .003) and distant metastasis (7/17 [41%] vs 0/10 [0%]; P = .026). Median PFI was 204 days (95% CI, 145 to 392). Median OS was 671 days (95% CI, 225 to upper limit not reached). Nodal metastasis at the time of surgery was associated with shorter PFI ( P = .017) but not OS ( P = .26). Adjuvant therapy was not associated with outcome. CLINICAL RELEVANCE Dogs with massive AGASACA experienced prolonged survival following anal sacculectomy despite a high incidence of local recurrence and metastasis. Lymph node metastasis at the time of surgery was a negative prognostic indicator for PFI but not OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- 1Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA.
- 2Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Zitieren
APA
Griffin, M. A., Mayhew, P. D., Culp, W. T. N., Giuffrida, M. A., Telek, S., Singh, A., Oblak, M., & Swanton, E. (2023). Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma. Journal of the American Veterinary Medical Association. https://doi.org/10.2460/javma.23.02.0102
Vancouver
Griffin MA, Mayhew PD, Culp WTN, Giuffrida MA, Telek S, Singh A, et al. Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma. Journal of the American Veterinary Medical Association. 2023. doi:10.2460/javma.23.02.0102
BibTeX
@article{Griffin2023,
author = {Griffin, Maureen A and Mayhew, Philipp D and Culp, William T N and Giuffrida, Michelle A and Telek, Stephanie and Singh, Ameet and Oblak, Michelle and Swanton, Emmett},
title = {Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma},
journal = {Journal of the American Veterinary Medical Association},
year = {2023},
doi = {10.2460/javma.23.02.0102}
}
EUVIMED